mci 9038 has been researched along with Blood Poisoning in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Asmis, LM; Bachler, M; Fries, D; Koscielny, J; Lang, T; Nowak, H; Paulus, P; Schewe, JC; von Heymann, C | 1 |
| Hage, A; Kiaii, B; Louzada, M | 1 |
| Fries, D | 2 |
| Behrend, K; Cerny, V; Fuchs, C; Hung, O; Ladwig, E; Lehmann, C; Murphy, M; Pavlovic, D; Whynot, S; Zhou, J | 1 |
| Csongrádi, E; Dreisbach, AW; Ferguson, LM; Fulop, T; Juncos, LA | 1 |
| Yamada, K | 1 |
3 review(s) available for mci 9038 and Blood Poisoning
| Article | Year |
|---|---|
Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review.
Topics: Anticoagulants; Arginine; COVID-19; Critical Illness; Heparin; Heparin, Low-Molecular-Weight; Humans; Pipecolic Acids; Sepsis; Sulfonamides; Thrombocytopenia; Thrombosis; Venous Thromboembolism | 2022 |
[Anticoagulation in critically ill patient].
Topics: Anticoagulants; Arginine; Biological Availability; Blood Coagulation Tests; Contraindications; Critical Care; Drug Monitoring; Heparin; Heparin, Low-Molecular-Weight; Humans; Pipecolic Acids; Pulmonary Embolism; Risk Factors; Sepsis; Shock, Septic; Sulfonamides; Venous Thrombosis | 2009 |
Thrombosis prophylaxis in critically ill patients.
Topics: Anticoagulants; Arginine; Biological Availability; Chromosome Breakage; Chromosome Disorders; Critical Care; Dose-Response Relationship, Drug; Drug Resistance; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Infusions, Intravenous; Injections, Subcutaneous; Pipecolic Acids; Recombinant Proteins; Risk Factors; Sepsis; Severity of Illness Index; Shock, Septic; Sulfonamides; Thrombin; Thrombocytopenia; Venous Thrombosis | 2011 |
4 other study(ies) available for mci 9038 and Blood Poisoning
| Article | Year |
|---|---|
Sepsis-induced heparin resistance during extracorporeal membrane oxygenation.
Topics: Adult; Anticoagulants; Antithrombins; Arginine; Drug Resistance; Extracorporeal Membrane Oxygenation; Female; Heparin; Humans; Pipecolic Acids; Sepsis; Sulfonamides; Thrombocytopenia | 2019 |
Argatroban administration reduces leukocyte adhesion and improves capillary perfusion within the intestinal microcirculation in experimental sepsis.
Topics: Animals; Anticoagulants; Arginine; Blood Pressure; Capillaries; Cell Adhesion; Disease Models, Animal; Heart Rate; Intestines; Leukocytes; Male; Microcirculation; Microscopy, Video; Myography; Pipecolic Acids; Rats; Rats, Inbred Lew; Sepsis; Splanchnic Circulation; Sulfonamides; Time Factors; Vasodilation | 2010 |
Recurring extracorporeal circuit clotting during continuous renal replacement therapy in fungal sepsis: successful treatment with argatroban.
Topics: Antifungal Agents; Antithrombins; Arginine; Blood Coagulation; Coronary Artery Bypass; Humans; Male; Mediastinitis; Middle Aged; Mycoses; Phosphorylcholine; Pipecolic Acids; Postoperative Complications; Renal Replacement Therapy; Scedosporium; Sepsis; Sulfonamides | 2013 |
A clinical trial of MD-805, a synthetic thrombin inhibitor, for the treatment of DIC.
Topics: Antithrombins; Arginine; Chemical Phenomena; Chemistry; Child; Disseminated Intravascular Coagulation; Female; Fibrinogen; Humans; Meningoencephalitis; Partial Thromboplastin Time; Pipecolic Acids; Platelet Count; Prothrombin Time; Pseudomonas Infections; Sepsis; Sulfonamides; Thrombin | 1983 |